 |
When was Symbollon founded?
Incorporated?
We were founded in 1986 and incorporated in Delaware in 1993.
How does Symbollon generate revenues?
We commercialized our first product, IodoZyme, in 1995. We
manufacture IodoZyme and sell it to our exclusive marketing partner,
West Agro, Inc. of Kansas City, MO. For products under development
with corporate partners, we might have two sources of revenue—milestone
payments and royalties. When we engage a partner to take our pharmaceuticals
to market, we will receive an upfront payment. We can receive additional
payments when we meet certain milestones during the development of
the product. The amount and timing of these payments depends on when,
in the development cycle, we engage the partner. Once our partner begins
to sell the drug, we will receive royalties, which will be an agreed-upon
percentage of sales of that product. Symbollon’s past agreements
with Bausch & Lomb Pharmaceuticals, Inc. and Oclassen Pharmaceuticals,
Inc. are two good examples of these types of relationships.
Can your products be sold outside the United States?
Yes. IodoZyme and our other products under development can be sold
throughout the world so long as the appropriate governmental authorizations
are received. Presently, IodoZyme is being marketed in the United Kingdom.
For any product, the specific countries where it will be sold will
be determined in conjunction with our future marketing partners.
Where are Symbollon’s headquarters?
Our headquarters are in Framingham, Massachusetts, just outside of
Boston. Our address is:
Symbollon Pharmaceuticals, Inc.
37 Loring Drive
Framingham, MA 01702
What is Symbollon's fiscal year?
Our fiscal year end is December 31.
When was the initial public offering of Symbollon stock, and what was
the price at the time?
Symbollon went public on December 7, 1993, selling 1.15 million units
(each unit consisting of one share of Class A common stock, one Class
A warrant and one Class B warrant) at $6.00 per unit. We are listed
on the OTCBB under the ticker “SYMBA.”
Does Symbollon pay a dividend?
Symbollon has never paid a cash dividend. The current policy of the
Board of Directors is to retain all earnings to fund our continued
growth.
Do you have plans for a stock split?
Not at the current time. The Board of Directors will make decisions
on any future stock splits.
Is there a way to purchase Symbollon stock directly from the company?
We do not have a direct stock purchase plan. However, you should be
able to buy our stock through any stock brokerage firm.
How do I transfer my stock or change my address with the transfer agent?
Please contact our transfer agent:
Name: American Stock Transfer & Trust Co.
Address: 59 Maiden Lane
New York, NY 10038
Phone: 212-936-5100
How can I obtain additional financial information about Symbollon or contact
Investor Relations?
Under the navigational button “Investor Relations”, click on the “SEC
Filings” button to view or download financial information. You can also
download our financials from our site under the “Investor Relations” section
under “Financials”. You can reach investor relations by calling
(508) 620-7676, ext. 250 or by sending an e-mail to pauldesjourdy@symbollon.com.
How can I find out about the performance of the stock?
To obtain more information on stock performance, under the navigational button “Investor
Relations”, click on the “Stock Quote” button. This includes
a historical stock performance chart.
|
